Vivek Podder, MBBS
@VPodder
Physician⏐ Postdoctoral Researcher ⏐ Author of First Aid for the USMLE Step 1 ⏐ Medical Editor ⏐ Patient Advocate
Talvez você curta
Now online: Repositioning GLP-1 Receptor Agonists in Endometrial Cancer: Molecular Rationale, Preclinical Insights, and Translational Opportunities doi.org/10.1158/1078-0…
Editorial: Comparative efficacy between 400-mg and 600-mg ribociclib doses in hormone receptor–positive breast cancer is clinically minimal, but differences in toxicity are significant. ja.ma/4ih8jV1
Join us for November Journal Club! Wednesday, November 19th, 2025 11:00-11:45 CST (18:00-18:45 CET). November Lead Article for Discussion: Checkpoint inhibitor rechallenge in advanced endometrial cancer: revisiting the immune landscape beyond first-line therapy…
✨ Don’t miss our next #IJGCclub! 🗓️ Nov 19 | 11:00 CDT (18:00 CEST) 📖 Checkpoint inhibitor rechallenge in advanced endometrial cancer with Brian M. Slomovitz, MD @GynCancerMD and Vivek Podder @VPodder (@SinaiHealth) 🔗 Don’t miss this engaging discussion:…
Emerging Therapeutics in Low-Grade Serous Ovarian Carcinoma - @VPodder oncodaily.com/voices/vivek-p… #Cancer #OncoDaily #Oncology #MedEd #MedTwitter #MedX #MedOnc @CancerWorldmag
#LeadArticle Checkpoint inhibitor rechallenge in advanced #endometrialcancer: revisiting the immune landscape beyond first-line therapy ✅ bit.ly/48W0QIh @pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert…
We just published in @TheLancetOncol a very important paper regarding the new FDA guidance on overall survival assessment in cancer drug trials. Right in time for #ESMO25. Please do read. I promise you that you’ll learn something that’s applicable broadly. And follow along this…
Validation of comprehensive genomic profiling for prognostic and potential therapeutic molecular classification of #endometrialcancer 🧬 bit.ly/48K1s3N @pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert…
Onclive State of the Science Coming to Miami 10/30 Hosted by @OncLive @MountSinaiMiami Join us for a great way to learn and to network with friends and colleagues. So honored have this distinguished group of Key Opinion Leaders as speakers @DrKatyMoore @IJGConline @GOG
NEW: FDA releases draft guidance on overall survival assessment in oncology trials, with an emphasis on analyzing overall survival as a pre-specified safety endpoint. fda.gov/regulatory-inf…
We need better treatments for our patients with advanced/metastatic cervix cancer!!! Open and accruing @MountSinaiMiami clinicaltrials.gov/study/NCT06459…
The man in seat 11A survived, but why don’t our patients? dlvr.it/TLRd9l #Physician #PrimaryCare via @kevinmd
The man in seat 11A survived, but why don’t our patients? kevinmd.com/2025/06/the-ma… via @kevinmd
Honored to be a co-investigator on this practice changing trial. @GOG @MountSinaiMiami
Study shows relacorilant + nab-paclitaxel improves PFS and OS in patients with platinum-resistant ovarian cancer. Dr Brian Slomovitz (@GynCancerMD) shares that the data; safety profile may suggest a new standard for patients with PROC 👇 ecancer.org/en/video/12397… #ASCO25
telemundo51.com/noticias/local… Honored to be investigator using Tisotumab Vedotin @pfizer @Genmab that received @FDAOncology @US_FDA approval for women with cervical cancer. Grateful to @Telemundo for helping to raise cervical cancer awareness @igcs @IJGConline @GOG @MountSinaiMiami
#Editorial The challenge is no longer whether precision oncology can improve outcomes in #endometrialcancer but how rapidly and effectively these advancements can be integrated into standard clinical practice. 📌 bit.ly/4363lDa @pedroramirezMD @HsuMd @JayrajAarthi…
pubmed.ncbi.nlm.nih.gov/40253116/ Does metformin work to cure #endometrialcancer? @vpodder @MountSinaiMiami @NRGonc @GOG @MountSinaiMiami
pubmed.ncbi.nlm.nih.gov/40233470/ Using precision molecular classifications to treat endometrial cancer! So many new options for our patients. @VPodder @MountSinaiMiami
Excited to share our new @IJGConline editorial: “Precision oncology in endometrial cancer: closing the gap between potential and practice” w/ @GynCancerMD We explore genomics, racial disparities, immunotherapy, & access barriers. Read here: sciencedirect.com/science/articl…
Endocrine Treatments for Patients Diagnosed with Endometrial Cancer in 2025 - @VPodder oncodaily.com/drugs/vivek-po… #Health #Medicine #Cancer #OncoDaily #Oncology #EndometrialCancer #EndocrineTherapy #MedX
oncodaily.com
Vivek Podder: Endocrine Treatments for Patients Diagnosed with Endometrial Cancer in 2025 -...
Vivek Podder: Endocrine Treatments for Patients Diagnosed with Endometrial Cancer in 2025 / Brian Slomovitz, cancer, Fernanda Musa, Kathleen Moore, OncoDaily,
United States Tendências
- 1. Hobbs N/A
- 2. #AEWDynamite N/A
- 3. Verizon N/A
- 4. Hubert N/A
- 5. #NYGiants N/A
- 6. Stanford N/A
- 7. Precious Achiuwa N/A
- 8. Jalen Brunson N/A
- 9. Koa Peat N/A
- 10. #VegasBorn N/A
- 11. Mike Brown N/A
- 12. AJ Dybantsa N/A
- 13. Boopie Miller N/A
- 14. Ebuka Okorie N/A
- 15. Isaiah Evans N/A
- 16. NFC East N/A
- 17. Eichel N/A
- 18. Yanic N/A
- 19. Mark Stone N/A
- 20. Walt N/A
Something went wrong.
Something went wrong.